Modulation of CRISPR-Cas9 Cleavage with an Oligo-Ribonucleoprotein Design

被引:0
|
作者
Gao, Yahui [1 ]
Ang, Yan Shan [1 ]
Yung, Lin-Yue Lanry [1 ]
机构
[1] Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 117585, Singapore
关键词
CRISPR Cas9; modulation of Cas9; DNA cleavage; DNA; genome editing; ENDONUCLEASE CAS9; TARGET BINDING; GUIDE RNA; DNA; SPECIFICITY; REVEALS; DETERMINANTS; NUCLEASES; INCREASE; SPCAS9;
D O I
10.1002/cbic.202400821
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Clustered regularly interspaced short palindromic repeats (CRISPR) associated protein Cas9 system has been widely used for genome editing. However, the editing or cleavage specificity of CRISPR Cas9 remains a major concern due to the off-target effects. The existing approaches to control or modulate CRISPR Cas9 cleavage include engineering Cas9 protein and development of anti-CRISPR proteins. There are also attempts on direct modification of sgRNA, for example, structural modification via truncation or hairpin design, or chemical modification on sgRNA such as partially replacing RNA with DNA. The above-mentioned strategies rely on extensive protein engineering and direct chemical or structural modification of sgRNA. In this study, we proposed an indirect method to modulate CRISPR Cas9 cleavage without modification on Cas9 protein or sgRNA. An oligonucleotide was used to form an RNA-DNA hybrid structure with the sgRNA spacer, creating steric hindrance during the Cas9 mediated DNA cleavage process. We first introduced a simple and robust method to assemble the oligo-ribonucleoprotein (oligo-RNP). Next, the cleavage efficiency of the assembled oligo-RNP was examined using different oligo lengths in vitro. Lastly, we showed that the oligo-RNP directly delivered into cells could also modulate Cas9 activity inside cells using three model gene targets with reduced off-target effects.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Genome editing by CRISPR-Cas9 technology in Petunia hybrida
    Chopy, M.
    Morel, P.
    Bento, S. Rodrigues
    Vandenbussche, M.
    XXVI INTERNATIONAL EUCARPIA SYMPOSIUM SECTION ORNAMENTALS: EDITING NOVELTY, 2020, 1283 : 209 - 217
  • [42] CRISPR-Cas9: A Potent Gene-editing Tool for the Treatment of Cancer
    Mishra, Gauri
    Srivastava, Kamakshi
    Rais, Juhi
    Dixit, Manish
    Singh, Vandana Kumari
    Mishra, Lokesh Chandra
    CURRENT MOLECULAR MEDICINE, 2024, 24 (02) : 191 - 204
  • [43] Establishing the allosteric mechanism in CRISPR-Cas9
    Nierzwicki, Lukasz
    Arantes, Pablo Ricardo
    Saha, Aakash
    Palermo, Giulia
    WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL MOLECULAR SCIENCE, 2021, 11 (03)
  • [44] Application of CRISPR-Cas9 in eye disease
    Wu, Wenyi
    Tang, Luosheng
    D'Amore, Patricia A.
    Lei, Hetian
    EXPERIMENTAL EYE RESEARCH, 2017, 161 : 116 - 123
  • [45] Advancements and Obstacles of CRISPR-Cas9 Technology in Translational Research
    You, Liting
    Tong, Ruizhan
    Li, Mengqian
    Liu, Yuncong
    Xue, Jianxin
    Lu, You
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2019, 13 : 359 - 370
  • [46] BoostMEC: predicting CRISPR-Cas9 cleavage efficiency through boosting models
    Zarate, Oscar A.
    Yang, Yiben
    Wang, Xiaozhong
    Wang, Ji-Ping
    BMC BIOINFORMATICS, 2022, 23 (01)
  • [47] Programmable RNA Cleavage and Recognition by a Natural CRISPR-Cas9 System from Neisseria meningitidis
    Rousseau, Beth A.
    Hou, Zhonggang
    Gramelspacher, Max J.
    Zhang, Yan
    MOLECULAR CELL, 2018, 69 (05) : 906 - +
  • [48] Single-Stranded DNA Cleavage by Divergent CRISPR-Cas9 Enzymes
    Ma, Enbo
    Harrington, Lucas B.
    O'Connell, Mitchell R.
    Zhou, Kaihong
    Doudna, Jennifer A.
    MOLECULAR CELL, 2015, 60 (03) : 398 - 407
  • [49] A benchmark of computational CRISPR-Cas9 guide design methods
    Bradford, Jacob
    Perrin, Dimitri
    PLOS COMPUTATIONAL BIOLOGY, 2019, 15 (08)
  • [50] BoostMEC: predicting CRISPR-Cas9 cleavage efficiency through boosting models
    Oscar A. Zarate
    Yiben Yang
    Xiaozhong Wang
    Ji-Ping Wang
    BMC Bioinformatics, 23